These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37173821)

  • 1. Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharmacol; 2023 Sep; 63(9):1045-1052. PubMed ID: 37173821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome.
    Krysiak R; Kowalcze K; Okopień B
    Pharmacology; 2023; 108(5):451-459. PubMed ID: 37536301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
    Krysiak R; Szkróbka W; Okopień B
    Pharmacol Rep; 2021 Feb; 73(1):261-268. PubMed ID: 32696349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Telmisartan on Cardiometabolic Risk Factors in Hypertensive Male Siblings of Women With Polycystic Ovary Syndrome.
    Krysiak R; Basiak M; Szkróbka W; Okopień B
    J Clin Pharmacol; 2021 Sep; 61(9):1165-1173. PubMed ID: 33837974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Lisinopril on Cardiometabolic Risk Factors in Men With Hypertension and Early-onset Androgenetic Alopecia: A Pilot Study.
    Krysiak R; Basiak M; Okopień B
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e738-e742. PubMed ID: 34321400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
    El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
    BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Cardiometabolic Effects of Bromocriptine in Men With Early-Onset Androgenic Alopecia.
    Krysiak R; Basiak M; Szkróbka W; Okopień B
    J Clin Pharmacol; 2023 Mar; 63(3):345-351. PubMed ID: 36222207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.
    Harmanci A; Cinar N; Bayraktar M; Yildiz BO
    Clin Endocrinol (Oxf); 2013 Jan; 78(1):120-5. PubMed ID: 22702394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of oral contraception on cardiometabolic risk factors in women with elevated androgen levels.
    Krysiak R; Gilowska M; Okopień B
    Pharmacol Rep; 2017 Feb; 69(1):45-49. PubMed ID: 27771529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharmacol; 2023 Aug; 63(8):886-894. PubMed ID: 37042432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
    Krysiak R; Kowalcze K; Bednarska-Czerwińska A; Okopień B
    Pharmacol Rep; 2019 Jun; 71(3):417-421. PubMed ID: 31003151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population.
    Aksun S; Sonu NC; Aygun S; Karakulak UN; Mumusoglu S; Yildiz BO
    J Endocrinol Invest; 2024 May; 47(5):1129-1137. PubMed ID: 37930586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do polycystic ovaries on ultrasound scan indicate decreased insulin sensitivity in sisters of women with polycystic ovary syndrome?
    Raskauskiene D; Jones PW; Govind A; Obhrai M; Clayton RN
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2063-7. PubMed ID: 15634726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
    Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
    J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.
    Harnois-Leblanc S; Hernandez MI; Codner E; Cassorla F; Oberfield SE; Leibel NI; Mathew RP; Ten S; Magoffin DA; Lane CJ; Goran MI; Azziz R; Baillargeon JP; Geller DH
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e912-e923. PubMed ID: 34752621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
    Heutling D; Schulz H; Nickel I; Kleinstein J; Kaltwasser P; Westphal S; Mittermayer F; Wolzt M; Krzyzanowska K; Randeva H; Schernthaner G; Lehnert H
    J Clin Endocrinol Metab; 2008 Jan; 93(1):82-90. PubMed ID: 17986642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.